Dental Bone and Graft Substitutes Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS250110 | Research Suite: Report (PDF) & Market Data (Excel)
The dental bone and graft substitutes are referred to the
material, including natural and synthetic both, such as allograft, xenografts,
etc. They are used in bone regeneration and in dental procedures such as
surgeries and implants, proving structural integrity and
stability.
MARKET
OVERVIEW
The market valuation of the dental bone and graft substitutes market was valued at approximately USD xx billion in 2023 and is projected to reach USD xx billion in 2034 exhibiting a CAGR of xx.x% during the forecast period of 2024-2034. The market is aligned with healthcare sector, which makes it a sustainable and growing market.
GROWTH
DRIVERS
The rise in the incidences of dental disorders is one of the primary and key drivers of the market. As WHO (World Health Organization) states, there is an estimated 2 billion people suffer from caries of permanent teeth and 514 million children suffer from caries of primary teeth, globally. Prevalence of the main oral diseases continues to increase globally with growing urbanization and changes in living conditions.
The rise in the aging population is another
significant driver of the market as they highly incident age-related bone
deterioration and tooth loss, contributing towards significant growth. The
United Nations highlights there is a rise in aging population where it is estimated
that by 2050 the global population of 22.0% will be aged 60 years or more. The
awareness campaign initiatives such as World Oral Health Day also drives the
market towards growth, leading to higher adoption of this techniques.
MARKET SEGMENTATION:
·
By Type- autograft,
allograft, alloplast, xenograft, synthetic bone graft and others
·
By Application- ridge
augmentation, sinus lift, periodontal defect regeneration, implant bone
regeneration and socket preservation
·
By Mechanism- Osteoconduction,
osteoinduction, osteopromotion and osteogenesis
·
By End Users-
hospitals and clinics
·
By Regions- North America,
Europe, Asia Pacific, South America, Middle East and Africa
Dental
Bone and Graft Substitutes Market Segment by Type Review:
In the autograft, the healthcare professionals uses patients bone tissue for the grafting driven by the no risk of immune rejection. An allograft is a material that is derived from one person and implanted in another person whereas a xenograft is a material derived from any nonhuman animal that is implanted in a human. The synthetic bone graft is referred to the synthetic or artificial material used to replace natural bone tissue.
Regional
Analysis:
North America is a significant market driven by the presence of high prevalence of dental disorders coupled with advanced healthcare sector. Europe is another significant market driven by the rise in aging population and rise in medical tourism, mainly for dental. APAC is significantly growing market driven by rapid rising dental disorders and expanding dental tourism. MEA is a promising market driven by investments in healthcare infrastructure. South America is another growing market driven by growing dental tourism.
Key
Challenges:
The dental bone and graft substitutes market are highly
incident to risk of infection and immune rejection, this may raise concern
among patients, hindering the market growth and adoption. Moreover, the market
faces competition from alternatives available in the market and it required
skilled professionals with expertise in dentistry where lack of skilled
personnel may hamper the market growth.
Competitive
Landscape:
In the highly competitive dental bone and graft substitutes
market, companies are investing heavily in research and development to innovate
and improve their products and services. They are also collaborating, forming
strategic partnerships, or acquiring other companies to gain access to new
market segments, enhance distribution networks, and increase market share.
The key news and development includes-
·
In April 2023, Henry Schein acquired a
majority ownership position in Biotech Dental, aiming to create a digital
workflow that provides a seamless journey for customers to increase case
acceptance and improve clinical outcomes for practitioners.
·
In March 2022, Dentsply Sirona Inc.
partnered with Platform for Better Oral Health in Europe. The goal is to
improve oral health and the prevention of oral diseases - as well as address
oral health inequalities and challenges.
·
In February 2022, Envista Holdings
Corporation (US) partnered with Vitaldent Group (Spain). This extended
agreement positions Envista as the preferred supplier of implants (Nobel
Biocare) and clear aligners (Spark).
·
In January 2022, Johnson & Johnson
partnered with Microsoft Corporation, Inc. The Johnson & Johnson Medical
Devices Companies (JJMDC) collaborated with Microsoft Corporation Inc, (US) to
enable and expand JJMDC’s secure and compliant digital surgery ecosystem.
·
In February 2024, ZimVie Inc. launched
its TSX Implant in Japan, enhancing its dental implant offerings with features
designed for immediate extraction and standard loading protocols, aiming to
compete in the premium dental implant market.
·
In November 2023, Keystone Dental
launched the GENESIS ACTIVE Implant System, a comprehensive dental implant
solution featuring innovative technologies designed to enhance implant
placement efficiency and aesthetic outcomes.
·
In March 2022, Envista Holdings
Corporation re-brands its dental imaging business to DEXIS, encompassing a
range of digital imaging solutions and devices like CBCT, handheld X-rays,
intraoral scanners, and surgical systems, alongside brands i-CAT,
Instrumentarium, SOREDEX, and NOMA.
Global
Key Players:
·
Rti Surgicals
·
Geistlich Pharma Ag
·
Dentium Co, Ltd.
·
Envista Holdings Corporation
·
Zimvie
·
Keystone Dental
· Other Players
Attributes |
Details |
Base Year |
2023 |
Trend Period |
2024 – 2034 |
Forecast Period |
2024 – 2034 |
Pages |
215 |
By Type |
Autograft, Allograft, Alloplast,
Xenograft, Synthetic Bone Graft And Others |
By Application |
Ridge Augmentation,
Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration And
Socket Preservation |
By Mechanism |
Osteoconduction,
Osteoinduction, Osteopromotion And Osteogenesis |
By End Users |
Hospitals and Clinics |
By region |
North America, Europe,
Asia Pacific, the Middle East and Africa, and South America |
Company Profiles |
Dentsply Sirona, Biohorizons
Inc., Zimmer Biomet, Rti Surgicals, Medtronic, Geistlich Pharma Ag, Dentium
Co, Ltd., Envista Holdings Corporation, Zimvie, Keystone Dental, Other
Players |
Edition |
1st edition |
Publication |
January 2025 |